These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 19361982)

  • 1. Hyperthermia dose-effect relationship in 420 patients with cervical cancer treated with combined radiotherapy and hyperthermia.
    Franckena M; Fatehi D; de Bruijne M; Canters RA; van Norden Y; Mens JW; van Rhoon GC; van der Zee J
    Eur J Cancer; 2009 Jul; 45(11):1969-78. PubMed ID: 19361982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotherapy and hyperthermia for treatment of primary locally advanced cervix cancer: results in 378 patients.
    Franckena M; Lutgens LC; Koper PC; Kleynen CE; van der Steen-Banasik EM; Jobsen JJ; Leer JW; Creutzberg CL; Dielwart MF; van Norden Y; Canters RA; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):242-50. PubMed ID: 18990505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term improvement in treatment outcome after radiotherapy and hyperthermia in locoregionally advanced cervix cancer: an update of the Dutch Deep Hyperthermia Trial.
    Franckena M; Stalpers LJ; Koper PC; Wiggenraad RG; Hoogenraad WJ; van Dijk JD; Wárlám-Rodenhuis CC; Jobsen JJ; van Rhoon GC; van der Zee J
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1176-82. PubMed ID: 17881144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional hyperthermia combined with radiotherapy for uterine cervical cancers: a multi-institutional prospective randomized trial of the international atomic energy agency.
    Vasanthan A; Mitsumori M; Park JH; Zhi-Fan Z; Yu-Bin Z; Oliynychenko P; Tatsuzaki H; Tanaka Y; Hiraoka M
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):145-53. PubMed ID: 15629605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature data analysis for 22 patients with advanced cervical carcinoma treated in Rotterdam using radiotherapy, hyperthermia and chemotherapy: a reference point is needed.
    Fatehi D; van der Zee J; van der Wal E; Van Wieringen WN; Van Rhoon GC
    Int J Hyperthermia; 2006 Jun; 22(4):353-63. PubMed ID: 16754355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiotherapy with 8-MHz radiofrequency-capacitive regional hyperthermia for stage III non-small-cell lung cancer: the radiofrequency-output power correlates with the intraesophageal temperature and clinical outcomes.
    Ohguri T; Imada H; Yahara K; Morioka T; Nakano K; Terashima H; Korogi Y
    Int J Radiat Oncol Biol Phys; 2009 Jan; 73(1):128-35. PubMed ID: 18513887
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot Phase II trial of concurrent radiotherapy, chemotherapy, and hyperthermia for locally advanced cervical carcinoma.
    Jones EL; Samulski TV; Dewhirst MW; Alvarez-Secord A; Berchuck A; Clarke-Pearson D; Havrilesky LJ; Soper J; Prosnitz LR
    Cancer; 2003 Jul; 98(2):277-82. PubMed ID: 12872345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
    Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The value of prognostic factors for uterine cervical cancer patients treated with irradiation alone.
    Grigiene R; Valuckas KP; Aleknavicius E; Kurtinaitis J; Letautiene SR
    BMC Cancer; 2007 Dec; 7():234. PubMed ID: 18154683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast.
    Kapp DS; Cox RS
    Int J Radiat Oncol Biol Phys; 1995 Nov; 33(4):887-99. PubMed ID: 7591899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy followed by radiotherapy and concurrent hyperthermia in patients with advanced-stage cervical cancer: a retrospective study.
    Heijkoop ST; Franckena M; Thomeer MG; Boere IA; Van Montfort C; Van Doorn HC
    Int J Hyperthermia; 2012; 28(6):554-61. PubMed ID: 22690721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thermal dosimetric study on hyperthermia combined with radiotherapy for deep seated pelvic malignancies].
    Wang RB; Yu JM; Li JL; Yu YH; Xu M; Li BS
    Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):99-101. PubMed ID: 15946549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-luminal thermometry: is tissue type assignment a necessity for thermal analysis?
    Fatehi D; Van Der Zee J; Wielheesen DH; Van Wieringen WN; Van Rhoon GC
    Int J Hyperthermia; 2006 Sep; 22(6):463-73. PubMed ID: 16971367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Weekly systemic cisplatin plus locoregional hyperthermia: an effective treatment for patients with recurrent cervical carcinoma in a previously irradiated area.
    Franckena M; De Wit R; Ansink AC; Notenboom A; Canters RA; Fatehi D; Van Rhoon GC; Van Der Zee J
    Int J Hyperthermia; 2007 Aug; 23(5):443-50. PubMed ID: 17701535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five years' experience treating locally advanced cervical cancer with concurrent chemoradiotherapy and high-dose-rate brachytherapy: results from a single institution.
    Parker K; Gallop-Evans E; Hanna L; Adams M
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):140-6. PubMed ID: 18922646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinoma.
    Westermann AM; Jones EL; Schem BC; van der Steen-Banasik EM; Koper P; Mella O; Uitterhoeve AL; de Wit R; van der Velden J; Burger C; van der Wilt CL; Dahl O; Prosnitz LR; van der Zee J
    Cancer; 2005 Aug; 104(4):763-70. PubMed ID: 15968685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cervical cancer: radiotherapy and hyperthermia.
    van der Zee J; van Rhoon GC
    Int J Hyperthermia; 2006 May; 22(3):229-34. PubMed ID: 16754343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: results of an IAEA multicentre randomised trial.
    Dobrowsky W; Huigol NG; Jayatilake RS; Kizilbash NI; Okkan S; Kagiya VT; Tatsuzaki H
    Radiother Oncol; 2007 Jan; 82(1):24-9. PubMed ID: 17161478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implementation of hyperthermia treatment planning guided steering: A cross over trial to assess its current contribution to treatment quality.
    Franckena M; Canters R; Termorshuizen F; Van Der Zee J; Van Rhoon G
    Int J Hyperthermia; 2010; 26(2):145-57. PubMed ID: 20146569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiotherapy doses at special reference points correlate with the outcome of cervical cancer therapy.
    Yoshimura R; Hayashi K; Ayukawa F; Toda K; Iwata M; Oota S; Hoshi A; Wakatsuki M; Kurosaki H; Okazaki A; Shibuya H
    Brachytherapy; 2008; 7(3):260-6. PubMed ID: 18579445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.